In March 2014, the Joint Committee on Vaccination and Immunisation (JCVI) recommended the vaccination of infants against meningococcal group B infection (MenB), to protect them from this strain of meningococcal bacteria.
There are 12 types of Meningococci (A, B, C, E, H, I, K, L, W, X, Y and Z). B, C, Y and W are the most common types in the UK. Since the introduction of the routine MenC programme in November 1999, the number of cases of MenC have greatly reduced.
Purpose and outline
The purpose of the service is to enable NHS England to commission MenB immunisation services of sufficient quantity and quality to prevent the infections and outbreaks caused by these organisms.
Currently, MenB accounts for 80% of cases of invasive meningococcal disease. Meningococcal disease is more common in children under 5 years, with a higher number of cases in babies under 12 months of age and a peak incidence at 5 months of age.
This routine programme is a 3 dose programme for babies aged 2, 4 and 12 to 13 months of age. The two doses at 2 and 4 months constitute the primary course required to ensure optimum protection for babies ahead of peak incidence at 5 months. The third dose at 12 to 13 months provides longer term protection.
Only babies born on or after 1 May 2015 will qualify for this programme. Children are not recommended for vaccination from 2 years of age.
Information about this service
Quality service start date: 1 April 2020
Quality service end date: 31 March 2021
Payment period: Monthly
Collection frequency: Monthly
Manual or automatic entry: Automatic
Included in data collection: All system suppliers (TPP, INPS, Microtest and Emis)
Last edited: 11 April 2020 7:58 am